
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GSK | NYSE | USD | Real-time | |
GSKl | BATS Europe | GBP | Delayed | |
GLAXF | OTC Markets | USD | Delayed | |
GSK | London | GBP | Real-time | |
GSKN | Mexico | MXN | Delayed | |
GS71 | Xetra | EUR | Delayed | |
GS71 | TradeGate | EUR | Delayed | |
GS70y | Frankfurt | EUR | Delayed | |
GS71 | Frankfurt | EUR | Delayed | |
GSK | Buenos Aires | ARS | Delayed |
Period Ending: | 2023 30/09 |
2023 30/06 |
2023 31/03 |
2022 31/12 |
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 8147 | 7178 | 6951 | 7376 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Cost of Revenue, Total | 2243 | 1899 | 1908 | 2186 | ||||||||||||||||||||||||||||||
Gross Profit | 5904 | 5279 | 5043 | 5190 | ||||||||||||||||||||||||||||||
Total Operating Expenses | 5591 | 5127 | 5182 | 5961 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Operating Income | 2556 | 2051 | 1769 | 1415 | ||||||||||||||||||||||||||||||
Interest Income (Expense), Net Non-Operating | - | - | - | - | ||||||||||||||||||||||||||||||
Gain (Loss) on Sale of Assets | - | - | 1 | 471 | ||||||||||||||||||||||||||||||
Other, Net | 765 | 64 | -139 | -682 | ||||||||||||||||||||||||||||||
Net Income Before Taxes | 1791 | 1987 | 1907 | 1626 | ||||||||||||||||||||||||||||||
Provision for Income Taxes | 257 | 242 | 276 | 1 | ||||||||||||||||||||||||||||||
Net Income After Taxes | 1534 | 1745 | 1631 | 1625 | ||||||||||||||||||||||||||||||
Minority Interest | -514 | -532 | -508 | -502 | ||||||||||||||||||||||||||||||
Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income Before Extraordinary Items | 1464 | 1624 | 1490 | 1500 | ||||||||||||||||||||||||||||||
Total Extraordinary Items | - | - | - | 501 | ||||||||||||||||||||||||||||||
Net Income | 1464 | 1624 | 1490 | 2001 | ||||||||||||||||||||||||||||||
Total Adjustments to Net Income | - | - | - | -501 | ||||||||||||||||||||||||||||||
Income Available to Common Excluding Extraordinary Items | 1464 | 1624 | 1490 | 1500 | ||||||||||||||||||||||||||||||
Dilution Adjustment | 0.128 | -0.921 | -1.02 | 500.72 | ||||||||||||||||||||||||||||||
Diluted Net Income | 1463.87 | 1624.92 | 1491.02 | 1500.28 | ||||||||||||||||||||||||||||||
Diluted Weighted Average Shares | 4112 | 4093 | 4085 | 4091 | ||||||||||||||||||||||||||||||
Diluted EPS Excluding Extraordinary Items | 0.356 | 0.397 | 0.365 | 0.367 | ||||||||||||||||||||||||||||||
DPS - Common Stock Primary Issue | 0.14 | 0.14 | 0.14 | 0.138 | ||||||||||||||||||||||||||||||
Diluted Normalized EPS | 0.348 | 0.26 | 0.209 | 0.148 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review